Trial intelligence / Profile preview

Dexmedetomidine-assisted PCIA after pediatric scoliosis surgery

ChiCTR2000041028Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Dec 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine and sufentanil in scoliosis (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Postoperative opioid analgesic dosage, Effective pressing times and total pressing times of analgesia pump and 1 more. Started Dec 2020; status: recruiting.

02

Drugs

dexmedetomidinesufentanil
03

Conditions

scoliosis

Beyond the preview

Go deeper on ChiCTR2000041028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000041028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call